Hospital Sao Domingos

São Luís, Maranhão 65060-645

1 studies enrolling now · 2 studies all time

What they study most

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Lymphoma, Mantle-Cell

Studies at this site

• A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) — Recruiting now
• Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) — Running, not enrolling